Inspire Medical Securities Case Enters Lead-Plaintiff Phase Ahead of Jan. 5 Deadline

Investors have until January 5 to ask the Minnesota court to lead a lawsuit alleging misstatements about the troubled Inspire V rollout.

Overview

The class action, City of Pontiac Reestablished General Employees' Retirement System v. Inspire Medical Systems, Inc., No. 0:25-cv-04247, is pending in the U.S. District Court for the District of Minnesota.
The putative class covers purchases of Inspire Medical stock from August 6, 2024 through August 4, 2025.
The complaint claims the company and executives misled investors about Inspire V demand and launch readiness, including training and onboarding, IT and customer approval systems, insurer claims software updates, and Medicare reimbursement.
On August 4, 2025, Inspire disclosed delays tied to incomplete center onboarding and claims-processing software that took effect July 1, reported weak demand and excess inventory, and slashed 2025 EPS guidance by more than 80%.
Inspire shares fell roughly 32% to $87.91 on August 5, 2025, and multiple law firms are urging investors to seek lead-plaintiff status by January 5, 2026 as the case remains un-certified.